Suppr超能文献

海藻糖缺陷突变株和 对两性霉素 B 和米卡芬净的敏感性。

Sensitivity of the trehalose-deficient mutants and to amphotericin B and micafungin.

机构信息

Área de Microbiología, Facultad de Biología, Universidad de Murcia, E-30100, Spain.

Servicio de Microbiología Clínica, Hospital Universitario Virgen de la Arrixaca, IMIB, Murcia, Spain.

出版信息

J Med Microbiol. 2019 Oct;68(10):1479-1488. doi: 10.1099/jmm.0.001053. Epub 2019 Aug 5.

Abstract

. Fungal infections have increased in recent decades, with being the fourth most common aetiological agent of nosocomial infections. Disaccharide trehalose has been proposed as a target for the development of new antifungals. In we have examined the susceptibility shown by two mutants deficient in trehalose biosynthesis, namely and , to amphotericin B (AmB) and micafungin (MF).. Minimum inhibitory concentrations (MICs) were calculated according to the Clinical and Laboratory Standards Institute (CLSI) criteria. Cell viability was assessed by cell counting. Intracellular reactive oxygen species (ROS) and the mitochondrial membrane potential were measured by flow cytometry, while the trehalose content and biofilm formation were determined by enzymatic assays.. While the mutant was highly sensitive to AmB exposure, its resistance to MF was similar to that of the wild-type. Notably, the opposite phenotype was recorded in the mutant. In turn, MF induced a significant level of endogenous ROS production in the parental SC5314 and cells, whereas the ROS formation in cells was virtually undetectable. The level of endogenous ROS correlated positively with the rise in mitochondrial activity. Only AmB was able to promote intracellular synthesis of trehalose in the parental strain; it was absent from cells and showed low levels in , confirming the unspecific dephosphorylation of trehalose-6P in . Furthermore, the capacity of both and mutants to form biofilms was drastically reduced after AmB exposure, whereas it increased in cells treated with MF.. Our data lend weight to the idea of using trehalose biosynthesis as a potential target for antifungal therapy.

摘要

真菌性感染在最近几十年有所增加,[此处为真菌名称]是医院感染的第四大常见病原体。二糖海藻糖已被提议作为开发新型抗真菌药物的靶标。在本研究中,我们研究了两种缺乏海藻糖生物合成的突变体[此处为突变体名称]对两性霉素 B(AmB)和米卡芬净(MF)的敏感性。根据临床和实验室标准协会(CLSI)标准计算最小抑菌浓度(MIC)。通过细胞计数评估细胞活力。通过流式细胞术测量细胞内活性氧(ROS)和线粒体膜电位,同时通过酶测定法确定海藻糖含量和生物膜形成。虽然[此处为突变体名称]突变体对 AmB 暴露高度敏感,但对 MF 的抗性与野生型相似。值得注意的是,在[此处为突变体名称]突变体中记录到相反的表型。反过来,MF 在亲本 SC5314 和[此处为突变体名称]细胞中诱导了显著水平的内源性 ROS 产生,而[此处为突变体名称]细胞中的 ROS 形成几乎无法检测到。内源性 ROS 水平与线粒体活性的升高呈正相关。只有 AmB 能够在亲本菌株中促进细胞内海藻糖的合成;它在[此处为突变体名称]细胞中不存在,并且在[此处为突变体名称]中含量较低,证实了海藻糖-6P 在[此处为突变体名称]中的非特异性去磷酸化。此外,AmB 暴露后,[此处为突变体名称]和[此处为突变体名称]突变体形成生物膜的能力大大降低,而在 MF 处理的[此处为突变体名称]细胞中增加。我们的数据支持将海藻糖生物合成作为抗真菌治疗的潜在靶标的想法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验